Ginkgolide B

银杏内酯B

Report date: 2026/05/13 20:02:10
NME

Base Information

Drug NameGinkgolide B
Drug Alias NameBN-52021
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlatelet activating factor receptor antagonists
TargetsPlatelet activating factor receptor
Therapy Area/IndicationsRejection of organ transplantationRejection of renal transplantationRejection of lung transplantation +[12] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesIpsen Inc
China Registration ClassN/A

Develop Information

Active CompaniesShandong Luoxin Pharmaceutical Group Stock Co Ltd
Inactive CompaniesPla General HospitalIpsen Inc
Active IndicationsIschemic Stroke
Inactive IndicationsRejection of organ transplantationRejection of renal transplantationRejection of lung transplantation +[11] 

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank